Bipolar Flashcards
Bipolar I
One or more manic or mixed episodes
Most also have some depression
Bipolar II
One or more depressive episodes + at least one hypomanic episode
Often misdiagnosed as MDD
Cyclothymic disorder
Several periods of hypomania and mild depression but do not meet criteria for mania, major depressive
Rapid cycling
At least 4 episodes of mania, hypomania, or depression in 1 year with 2 months between episodes
Bipolar I treatment of choice
Lithium
Lithium onset
Antimania: 1-2 weeks. May need adjunctive benzo or antipsychotic to control symptoms
Antidepressant effect: 6-8 weeks
Lithium monitoring labs
Baseline: CBC, electrolytes, renal function, thyroid function, UA, ECG, pregnancy test
every 6-12 months: Renal function, thyroid function, UA
Order serum concentration 12 hours after last dose, 5-6 days after initiation
Lithium serum concentration for acute mania
0.8-1.2
Lithium serum concentration for maintenance
0.6-1.0
Lithium toxicity
Lethargy
Coarse tremor
Confusion
Seizures
Coma
Death
Treatment of choice if severe: hemodialysis
Intervention if rash, psoriasis from lithium
D/C drug (temporary or permanent)
Intervention of tremor from lithium
Decrease dose
Add BB
Intervention if CNS toxicity from lithium
Reduce dose
Intervention if GI upset from lithium
Reduce dose
Try ER
Split doses
Intervention if hypothyroid from lithium
Levothyroxine
D/C lithium if necessary
Intervention if polydipsia or polyuria from lithium
Reduce dose
Manage fluid intake
Change to single bedtime dose
Intervention if interstitial fibrosis or glomerulosclerosis from lithium
Lower dose to achieve lowest effective concentration
Avoid dehydration
Lithium and pregnancy
Avoid during first trimester
Agents to avoid with lithium
Thiazides
Furosemide
NSAIDs
ACE-Is
All increase lithium plasma concentrations and could cause toxicity
Theophylline and lithium
lowers lithium concentration
Neuromuscular blockers and lithium
lithium may prolong neuromuscular blocker effect
Lithium and carbamazepine
Increase CNS toxicity
Not contraindication, but not commonly combined in practice
Lithium and neuroleptics
Lithium may potentiate EPS
Lithium and the thyroid
Lithium decreases synthesis and release of thyroid hormone, thus causing hypothyroidism
Dehydration, salt restriction, extrarenal salt loss on lithium
Increases sodium reabsorption which increases lithium plasma concentration
Decreased renal function and lithium
Decreased GFR and increased creatinine/BUN will increase lithium plasma concentration
Aging and lithium
Aging decreases GFR and increases sensitivity to ADRs. Will need to decrease lithium requirements.
Divalproex/Valproate for bipolar
As effective as lithium
Better for rapid cycling than depressive episodes
Divalproex/valproate BBW
Hepatotoxicity (LFTs monitored routinely)
Mitochondrial disease (increases risk for liver failure)
Fetal risk
Pancreatitis
Divalproex/valproate serum concentration
50-125 but usually target level at when achieve clinical response
> 80: neurotoxicity, sedation, hair loss, thrombocytopenia
Divalproex enteric coated to ER dosage form
Increase dose 8-20% due to less bioavailability with ER form
Carbamazepine for bipolar
Only for acute mania and maintenance therapy
Strong inducer and autoinducer, so can take time to come to steady state
Lamotrigine in bipolar
Approved for maintenance therapy. Best at preventing depressive episodes compared to manic episodes
Not effective in acute phase due to long titration
Missed lamotrigine doses
If miss >3-5 half lives (5 days), reinitiate from starting dose
Lamotrigine + valproic acid
increased risk for SJS rash
Lamotrigine rare ADRs
SJS
Aseptic meningitis
Hemophagocytic lymphohistiocytosis (HLH)
SGAs for acute bipolar treatment
All FDA approval except brexpiprazole, clozapine, iloperidone, lumateperone, lurasidone
First line agents for acute mania:
Aripiprazole
Asenapine
Cariprazine
Paliperidone
Quetiapine
Risperidone
SGAs for bipolar depression
Cariprazine
Quetiapine
Lumateperone
Lurasidone
Olanzapine + fluoxetine
SGA for bipolar maintenance
Risperal Consta
Abilify Maintena
Olanzapine
Quetiapine
Antidepressants and Bipolar
Avoid monotherapy as it can switch to manic phase (highest risk with TCA and SNRI)
Avoid if symptoms of mania present
Type II Bipolar treatment
First-line agent = lithium, but remember takes 6-8 weeks for depressive symptom resolution
Acute phase: Quetiapine, lurasidone
Maintenance: lamotrigine
Olanzapine + fluoxetine